Additionally, histone acetylation is widely modulated in TAMs: tumor TAMs often have low expression of class II HDACs (e.g., HDAC9, HDAC10), leading to hyperacetylation and activation of genes that paradoxically encourage macrophages to be trophic rather than toxic to tumors. This evidence concerns the gene HDAC9 and neoplasm.